1. Articles from NinePoint Medical Inc

    1-24 of 29 1 2 »
    1. NinePoint Medical Announces FDA Clearance for Pancreatic and Biliary Applications of the NvisionVLE® Imaging System

      NinePoint Medical Announces FDA Clearance for Pancreatic and Biliary Applications of the NvisionVLE® Imaging System

      NinePoint Medical, Inc ., a transformative medical device company pioneering the use of a real-time optical imaging platform for gastrointestinal applications, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the NvisionVLE® Imaging System for use in the pancreas and bile duct. These anatomical indications add to the previously existing esophageal applications for NinePoint’s state-of-the-art Optical Coherence Tomography (OCT) imaging platform. The NvisionVLE Imaging System provides physicians real-time, high-resolution volumetric images of the tissue surface and subsurface. This allows gastroenterologists to thoroughly evaluate tissue for regions of interest that may not be visible ...

      Read Full Article
    2. NinePoint Medical Announces FDA Clearance of an Artificial Intelligence Software Upgrade for the NvisionVLE Imaging System

      NinePoint Medical Announces FDA Clearance of an Artificial Intelligence Software Upgrade for the NvisionVLE Imaging System

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of a real-time imaging platform for gastrointestinal applications, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its Intelligent Real-time Image Segmentation™ (IRIS) software upgrade for its flagship product, the NvisionVLE Imaging System. IRIS, an artificial intelligence-based platform for image feature segmentation, is the first tool of its kind approved for use in imaging of esophageal tissue. The NvisionVLE Imaging System allows physicians to perform a Volumetric Laser Endomicroscopy (VLE) procedure that produces real-time, high-resolution cross-sectional images. This system enables gastroenterologists to ...

      Read Full Article
    3. NinePoint Medical, Inc. Enters Into A Strategic Partnership and Worldwide Distribution with Merit Medical Systems, Inc.

      NinePoint Medical, Inc. Enters Into A Strategic Partnership and Worldwide Distribution with Merit Medical Systems, Inc.

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of Optical Coherence Tomography (OCT) for gastrointestinal applications, today announced a long-term strategic partnership with Merit Medical Systems, Inc. (NASDAQ: MMSI ). This partnership includes a strategic investment and a worldwide distribution agreement with Merit Medical’s endoscopic division, Merit Medical Endotek® (Endotek), for NinePoint Medical’s NvisionVLE® Imaging System with Real-time Targeting™. This partnership combines the world-class Gastrointestinal (GI) and Pulmonary medical devices from Endotek with the ground-breaking Advanced OCT platform from NinePoint Medical. This OCT platform has, in a short period of time, become a primary imaging device ...

      Read Full Article
    4. New Clinical Data Presented at the World Congress of Gastroenterology @ ACG 2017 Shows Increased Dysplasia Detection Using Volumetric Laser Endomicroscopy with Laser Marking

      New Clinical Data Presented at the World Congress of Gastroenterology @ ACG 2017 Shows Increased Dysplasia Detection Using Volumetric Laser Endomicroscopy with Laser Marking

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of Optical Coherence Tomography (OCT) for gastrointestinal applications, today announced exciting new clinical data which was presented at the Plenary session at the World Congress of Gastroenterology @ the ACG 2017 in Orlando, FL. This data highlights clinical results achieved using the NvisionVLE ® Imaging System with Real-time Targeting™ - NinePoint Medical’s groundbreaking technology enabling Volumetric Laser Endomicroscopy (VLE) scanning of the esophagus and subsequent laser marking of concerning regions for pathological examination. Dr. Arvind Trindade and his colleagues from the Northwell Health System studied 369 consecutive patients that received endoscopic ...

      Read Full Article
    5. NinePoint Medical is featuring the NvisionVLE® Imaging System with Real-time Targeting™ at ACG 2017; Eight Scientific Abstracts to be Presented

      NinePoint Medical is featuring the NvisionVLE® Imaging System with Real-time Targeting™ at ACG 2017; Eight Scientific Abstracts to be Presented

      Visit us at ACG 2017! Booth #825 NinePoint Medical is featuring the NvisionVLE ® Imaging System with Real-time Targeting™ at ACG 2017; Eight Scientific Abstracts to be Presented NinePoint Medical, Inc., a transformative medical device company pioneering the use of an advanced imaging platform for gastrointestinal applications, today announced that new clinical data relating to its proprietary NvisionVLE ® Imaging System with Real-time Targeting™ will be presented at two upcoming major conferences. Seven clinical abstracts will be featured at the World Congress of Gastroenterology @ the ACG 2017 conference taking place October 13-18 in Orlando, FL, and one poster session will be presented ...

      Read Full Article
    6. NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      – NinePoint Medical, Inc., a transformative medical device company pioneering the use of advanced Optical Coherence Tomography (OCT) for gastrointestinal applications, will be featuring the NvisionVLE® Imaging System with Real-time Targeting™ at Digestive Disease Week® (DDW) 2017, which will be held May 6-9 in Chicago. In addition, results from various studies utilizing this technology in gastroenterology will be presented in 24 scientific abstracts throughout the conference. Random biopsy is the current standard of care for diagnosing esophageal diseases such as Barrett’s esophagus, squamous cell carcinoma, and adenocarcinoma. However, random biopsies assess less than 3% of the esophageal surface1 , leaving more ...

      Read Full Article
    7. NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE Imaging System with Real-time Targeting

      NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE Imaging System with Real-time Targeting

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of an advanced imaging platform for gastrointestinal applications, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has published its 2017 final fee schedule. The annual update includes a material increase to the reimbursement rate for CPT Code 43252 1 ( upper GI endoscopy with optical endomicroscopy ), used for esophageal procedures using the NvisionVLE Imaging System with Real-time Targeting. According to the final 2017 CMS fee schedule, starting January 1, 2017, the reimbursement rate for CPT code 43252 in the hospital out-patient setting increases 131% from $1 ...

      Read Full Article
    8. NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016

      NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of an advanced imaging platform for gastrointestinal applications, announced today that it has completed the primary phase of its Registry for High Resolution Optical Imaging of the Esophagus Using the NvisionVLE ® Imaging System. Results from the registry’s interim analysis will be presented in 11 scientific abstracts accepted to Digestive Disease Week ® (DDW) 2016, to be held May 21-24 in San Diego, California.

      Read Full Article
    9. NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.

      NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.

      NinePoint Medical, Inc., a transformative medical device company pioneering the use of a real-time imaging platform for gastrointestinal applications, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Real-time Targeting™ feature for its flagship product, the NvisionVLE ® Imaging System. In addition, the first procedures with this new system were performed at Beth Israel Deaconess Medical Center in Boston, Massachusetts. The NvisionVLE Imaging System employs proprietary Optical Coherence Tomography (OCT) technology allowing physicians to perform a Volumetric Laser Endomicroscopy (VLE) procedure that produces real-time, high-resolution cross-sectional images. This system enables gastroenterologists ...

      Read Full Article
    10. NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales

      NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales

      NinePoint Medical, Inc., a transformative medical device company that is pioneering the clinical use of a real-time imaging platform based upon a proprietary optical coherence tomography (OCT) technology, announced today the appointment of John Temple as Vice President of Sales. Mr. Temple reports directly to NinePoint Medical’s President and CEO, Christopher R. von Jako, Ph.D. “We are delighted to welcome such an accomplished sales executive to the NinePoint Medical team. Not only does John bring tremendous commercial leadership experience, but also in-depth gastroenterology industry knowledge and relationships,” said Dr. von Jako. “John’s exceptional track record will be ...

      Read Full Article
    11. New Clinical Data Using the NvisionVLE® Imaging System to be Presented at Digestive Disease Week® 2015

      New Clinical Data Using the NvisionVLE® Imaging System to be Presented at Digestive Disease Week® 2015

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced imaging, today announced that new clinical data relating to its proprietary NvisionVLE ® Imaging System, will be presented in a series of oral and poster presentations during Digestive Disease Week ® (DDW ® ) 2015. The annual meeting will take place May 16-19th in Washington, DC. The schedule for scientific presentations related to advanced optical coherence tomography (OCT) and the NvisionVLE ® Imaging System at DDW 2015 is provided below. SATURDAY, May 16, 2015 Three posters will be presented on Saturday, May 16 at 9:30am in Hall C of Walter ...

      Read Full Article
    12. NinePoint Medical Receives 2014 MDEA Silver Medal for NvisionVLE Imaging System

      NinePoint Medical Receives 2014 MDEA Silver Medal for NvisionVLE Imaging System

      NinePoint Medical, Inc., an emerging leader in the development of medical devices for advanced optical imaging, today announced the company was honored with a silver medal at the 2014 Medical Design Excellence Awards (MDEA) for the company’s volumetric optical coherence tomography device, the NvisionVLE Imaging System™. NinePoint and NvisionVLE were among 54 cutting-edge products and companies across 11 medical technology product categories selected as finalists. “Our team has worked diligently over the past four years to bring the NvisionVLE Imaging System to clinicians and patients, and we are pleased that our efforts were recognized by the MDEA with this ...

      Read Full Article
    13. New Clinical Data using the NvisionVLE™ Imaging System to be presented at Digestive Disease Week® 2014

      New Clinical Data using the NvisionVLE™ Imaging System to be presented at Digestive Disease Week® 2014

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced optical imaging, today announced that new clinical data, by various investigators using its proprietary NvisionVLE ™ Imaging System, will be presented in a series of 13 oral, video and poster presentations during Digestive Disease Week ® (DDW ® ) 2014. The annual meeting will take place May 3-6 at McCormick Place in Chicago. The schedule for scientific presentations related to advanced optical coherence tomography (OCT) and the NvisionVLE Imaging System at DDW 2014 is provided below. The NvisionVLE Imaging System is indicated for use as an imaging tool in the ...

      Read Full Article
    14. NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging System

      NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging System

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced optical imaging, today announced it has completed a $34 million Series B financing led by Corning Incorporated (NYSE: GLW), along with founding investors Third Rock Ventures and Prospect Venture Partners. The company also announced the addition of three new members to its board of directors: Curt Weinstein from Corning, and independent directors Tom Miller and Mark Stautberg. Proceeds from the financing will support the ongoing commercial launch of the NvisionVLE Imaging System in the U.S., as well as development of the company’s expanded product ...

      Read Full Article
    15. NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE™ Imaging System

      NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE™ Imaging System

      NinePoint Press Release - NinePoint Medical, Inc., an emerging leader in the development of medical devices for advanced optical imaging, today announced the commercial launch of its proprietary NvisionVLE ™ Imaging System in the United States. In addition, NinePoint today announced the launch of its newly redesigned website, www.ninepointmedical.com . In December 2011, the NvisionVLE Imaging System received 510(k) clearance from the U.S. Food and Drug Administration for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross sectional, real-time depth visualization. Last month, NinePoint received 510(k) clearance to expand the System ...

      Read Full Article
    16. NinePoint Medical to Present NvisionVLE Clinical Data at Digestive Disease Week 2013

      NinePoint Medical to Present NvisionVLE Clinical Data at Digestive Disease Week 2013

      NinePoint Medical Press Release - NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, today announced that new clinical data on its proprietary NvisionVLE ™ Imaging System will be featured in five poster presentations during Digestive Disease Week (DDW) taking place May 18-21, 2013, in Orlando, Fla. In addition, researchers from Massachusetts General Hospital (MGH) will highlight the core imaging technology of NvisionVLE, as well as a follow-on confocal endomicroscopy system, in two oral and two poster presentations. NinePoint licensed the imaging technology from MGH in 2010 as part of the largest intellectual property agreement ...

      Read Full Article
    17. NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System

      NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System

      NinePoint Medical Press Release - NinePoint Medical, Inc. , an emerging leader in the development of medical devices for in vivo imaging, today announced that it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NvisionVLE ™ Imaging System, expanding the system’s indication to include imaging of esophageal tissue microstructure. In January 2012, the company announced 510(k) clearance from the FDA to market its NvisionVLE Imaging System for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross sectional, real-time depth visualization. “The NvisionVLE Imaging System ...

      Read Full Article
    18. NinePoint Medical Imaging Technology Profiled in Three Recent Publications

      NinePoint Medical Imaging Technology Profiled in Three Recent Publications

      NinePoint Medical Press Release - Data Demonstrates OCT Imaging in Pulmonary Applications NinePoint Medical, Inc. , an emerging leader in the development of medical devices for in vivo imaging, today announced that data featuring its core imaging technologies were recently published in three major pulmonary journals. This research from Massachusetts General Hospital (MGH), highlighting pulmonary applications of advanced optical coherence tomography (OCT) and optical frequency domain imaging (OFDI), was featured in the American Journal of Respiratory and Critical Care Medicine , CHEST and the Journal of Visual Experiments. The technology has been licensed by NinePoint Medical from MGH and is currently in the ...

      Read Full Article
    19. NinePoint Medical Imaging Technology Highlighted in Nature Medicine

      NinePoint Medical Imaging Technology Highlighted in Nature Medicine

      NinePoint Medical Press Release - NinePoint Medical, Inc . , an emerging leader in the development of medical devices for in vivo imaging, today announced that data demonstrating positive results related to a new tethered capsule endomicroscopy technology, licensed from Massachusetts General Hospital (MGH), were published online this week in the journal Nature Medicine . The research, performed at the Wellman Center for Photomedicine at MGH, where the technology was developed, shows the pill-sized imaging system creates detailed, microscopic, three-dimensional images of the esophageal wall and is expected to offer several advantages over traditional endoscopy. This tethered capsule endomicroscopy technology has been licensed for ...

      Read Full Article
    20. NinePoint Medical Announces Data from Clinical Trial of NvisionVLE Imaging System Presented at Key Medical Meetings

      NinePoint Medical Announces Data from Clinical Trial of NvisionVLE Imaging System Presented at Key Medical Meetings

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for in vivo imaging, today announced that positive data from the company’s ongoing clinical trial to evaluate high-resolution optical imaging of Barrett’s esophagus using its proprietary NvisionVLE ™ Imaging System will be presented at three key medical meetings in the U.S. and Europe. In the two studies conducted at the Mayo Clinic in Jacksonville, Fla. and Rochester, Minn., the NvisionVLE Imaging System’s high resolution and wide-field imaging enabled the detection of dysplasia that was missed with the standard biopsy protocol. “We are excited to see ...

      Read Full Article
    21. NinePoint Medical Continues to Strengthen Leadership Team with Two New Members; Also Selected to 2012 “Fierce 15” List of Innovative Companies by Fierce Medical Devices

      NinePoint Medical Continues to Strengthen Leadership Team with Two New Members; Also Selected to 2012 “Fierce 15” List of Innovative Companies by Fierce Medical Devices

      NinePoint Press Release - Company Appoints Chief Financial Officer and Vice President of Sales NinePoint Medical, Inc. , an emerging leader in the development of medical devices for in vivo imaging, today announced that it has expanded its leadership team with the appointments of Judy Huber to chief financial officer and Kurt Heine to vice president of sales. In addition, FierceMedicalDevices today named NinePoint Medical to its inaugural “Fierce 15” list, designating it as one of the leading medical device and diagnostic companies of 2012. “It is an honor to be among the innovative companies selected for FierceMedicalDevices’ first Fierce 15 list ...

      Read Full Article
    22. Product Manager/Senior Product Manager Opening at NinePoint Medical

      Product Manager/Senior Product Manager Opening at NinePoint Medical

      NinePoint Medical, Inc. is developing, manufacturing and commercializing medical devices that enable in vivo pathology. Initial products will integrate breakthrough optical imaging technologies with advanced algorithmic processes to provide physicians with real-time decision making capabilities and image-guided therapies during minimally invasive procedures. The Company’s vision is to provide products that ultimately streamline care and improve patient outcomes. Headquartered in Cambridge, MA, NinePoint is backed by Third Rock Ventures and Prospect Venture Partners. Position Requirements The qualified candidate will be responsible for developing brand strategies and tactics to achieve successful market entry into key strategic product areas with the end ...

      Read Full Article
    23. NinePoint Medical Receives European CE Mark Approval and ISO for NvisionVLE Imaging System

      NinePoint Medical Receives European CE Mark Approval and ISO for NvisionVLE Imaging System

      NinePoint Press Release - Key Milestones Achieved as Company Prepares for 2013 Commercial Launch of Next-Generation Imaging Technology in U.S. and Europe NinePoint Medical, Inc. , an emerging leader in the development of medical devices for in vivo pathology, today announced that it has received European CE mark approval for the NvisionVLE ™ Imaging System. The CE Mark is for the company’s “optical endomicroscopy imaging devices for diagnosis of mucosa and submucosa diseases.” The company has also received ISO 13485:2003 certification, an international standard governing the requirements of a quality management system for medical devices and related services, for the ...

      Read Full Article
    24. NinePoint Medical to Unveil NvisionVLE Imaging System at DDW 2012

      NinePoint Medical to Unveil NvisionVLE Imaging System at DDW 2012

      Ninepoint Medical Press Release - NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo pathology, today announced that the company will preview its next-generation optical imaging technology, the NvisionVLE™ Imaging System, at Digestive Disease Week 2012 (DDW 2012), being held May 19 to 22 at the San Diego Convention Center in San Diego. NinePoint Medical will provide public demonstrations of the NvisionVLE Imaging System, which is designed to bridge the gap between diagnosis and disease treatment by enabling physicians and pathologists to evaluate high-resolution, volumetric images of organs and tissues in real time. “We are ...

      Read Full Article
    1-24 of 29 1 2 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (29 articles) NinePoint Medical
    2. (16 articles) FDA
    3. (11 articles) Charles Carignan
    4. (10 articles) Massachusetts General Hospital
    5. (5 articles) Patrick MacCarthy
    6. (3 articles) Boston Scientific
    7. (2 articles) Eman Namati
    8. (2 articles) Olympus
    9. (1 articles) Academic Medical Center at the University of Amsterdam
    10. (1 articles) University College London
  3. Popular Articles

  4. Picture Gallery

    NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System NinePoint Medical Initiates Clinical Trial of Nvision VLE Imaging System; Program On Track for Commercial Launch in 2013 Vice President of Sales Position Opening at NinePoint Medical NinePoint Medical to Unveil NvisionVLE Imaging System at DDW 2012 NinePoint Medical Receives European CE Mark Approval and ISO for NvisionVLE Imaging System NinePoint Medical Continues to Strengthen Leadership Team with Two New Members; Also Selected to 2012 “Fierce 15” List of Innovative Companies by Fierce Medical Devices New Clinical Data Using the NvisionVLE® Imaging System to be Presented at Digestive Disease Week® 2015 NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S. NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE Imaging System with Real-time Targeting Monitoring fatigue damage in different CAD/CAM materials: A new approach with optical coherence tomography. Automatic diagnosis of macular diseases from OCT volume based on its two-dimensional feature map and convolutional neural network with attention mechanism.